Search results
-
The Flaxil Label (A)
Barron, GregoryCase HBS-909001-EService and Operations ManagementThis case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite qualitative and differs from the typical price negotiation with which students are familiar. However, at stake was $500 million in Flaxil sales and the safety of millions of patients. The (A)...Starting at €8.20
-
The Flaxil Label (B)
Barron, GregoryCase HBS-909002-EService and Operations ManagementThis case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite qualitative and differs from the typical price negotiation with which students are familiar. However, at stake was $500 million in Flaxil sales and the safety of millions of patients. The (B)...Starting at €5.74
-
The Flaxil Label (A), (B), and (C), Teaching Note
Barron, GregoryTeaching Note HBS-909004-EService and Operations ManagementTeaching Note for [909001]. [909002], and [909003].Starting at €0.00
-
Unique - Yanbal (A)
Pancorvo, Jorge; Cuneo, SergioCase PAD-P-C-406 ING-EService and Operations ManagementA peruvian company facing regional supply chain challenges within the door to door cosmetics industryStarting at €8.20
-
Unique - Yanbal (A)
Pancorvo, Jorge; Cuneo, SergioCase PAD-P-C-406Service and Operations ManagementUna empresa peruana acometiendo retos de su cadena de suministros regional dentro de la industria de cosmeticos puerta a puertaStarting at €8.20